The effect of a single SMARCA4 exon deletion on RNA splicing: Implications for variant classification
Molecular Genetics & Genomic Medicine · 2023
DOI: 10.1002/mgg3.2232 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2023. Verfasst von Anna Byrjalsen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Transcription Factors, Nuclear Proteins, DNA Helicases, RNA Splicing. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Børnecancerfonden, Ingeniør Otto Christiensens Fond, Neye Fonden.
Abstract (Originalsprache)
Background
Exon deletions are generally considered pathogenic, particularly when they are located out of frame. Here, we describe a pediatric, female patient presenting with hypercalcemia and a small cell carcinoma of the ovary, hypercalcemic type, and carrying a germline de novo SMARCA4 exon 14 deletion.
Methods
The SMARCA4 deletion was identified by whole genome sequencing, and the effect on the RNA level was examined by gel‐ and capillary electrophoresis and nanopore sequencing.
Results
The deletion was in silico predicted to be truncating, but RNA analysis revealed two major transcripts with deletion of exon 14 alone or exon 14 through 15, where the latter was located in‐frame. Because the patient's phenotype matched that of other patients with pathogenic germline variants in SMARCA4 , the deletion was classified as likely pathogenic.
Conclusion
We propose to include RNA analysis in classification of single‐exon deletions, especially if located outside of known functional domains, as this can identify any disparate effects on the RNA and DNA level, which may have implications for variant classification using the American College of Medical Genetics and Genomics guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Pediatrics, Aarhus University Hospital, Aarhus N, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Anna Byrjalsen
Förderung
- Børnecancerfonden
- Ingeniør Otto Christiensens Fond
- Neye Fonden
- Region Hovedstaden
- Rigshospitalet
Zitieren
APA
Byrjalsen, A., Stoltze, U., Mehrjouy, M., Frederiksen, J. H., Bak, M., Birkedal, U., Hasle, H., Gerdes, A. M., Schmiegelow, K., Wadt, K., & Hansen, T. V. O. (2023). The effect of a single SMARCA4 exon deletion on RNA splicing: Implications for variant classification. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2232
Vancouver
Byrjalsen A, Stoltze U, Mehrjouy M, Frederiksen JH, Bak M, Birkedal U, et al. The effect of a single SMARCA4 exon deletion on RNA splicing: Implications for variant classification. Molecular Genetics & Genomic Medicine. 2023. doi:10.1002/mgg3.2232
BibTeX
@article{Byrjalsen2023,
author = {Byrjalsen, Anna and Stoltze, Ulrik and Mehrjouy, Mana and Frederiksen, Jane Hübertz and Bak, Mads and Birkedal, Ulf and Hasle, Henrik and Gerdes, Anne-Marie and Schmiegelow, Kjeld and Wadt, Karin and Hansen, Thomas van Overeem},
title = {The effect of a single SMARCA4 exon deletion on RNA splicing: Implications for variant classification},
journal = {Molecular Genetics & Genomic Medicine},
year = {2023},
doi = {10.1002/mgg3.2232}
}
EUVIMED